BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harwell JI, Brown RB. The Drug-Resistant Pneumococcus. Chest 2000;117:530-41. [DOI: 10.1378/chest.117.2.530] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Jackson LA, Neuzil KM. Pneumococcal polysaccharide vaccines. Vaccines. Elsevier; 2008. pp. 569-604. [DOI: 10.1016/b978-1-4160-3611-1.50028-3] [Cited by in Crossref: 10] [Article Influence: 0.7] [Reference Citation Analysis]
2 Menaker J, Martin IBK, Hirshon JM. Marked elevation of cerebrospinal fluid white blood cell count: An unusual case of Streptococcus pneumoniae meningitis, differential diagnosis, and a brief review of current epidemiology and treatment recommendations. The Journal of Emergency Medicine 2005;29:37-41. [DOI: 10.1016/j.jemermed.2004.12.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
3 Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL; American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001;163:1730-54. [PMID: 11401897 DOI: 10.1164/ajrccm.163.7.at1010] [Cited by in Crossref: 1442] [Cited by in F6Publishing: 1156] [Article Influence: 68.7] [Reference Citation Analysis]
4 McGowan JE Jr. Increasing threat of Gram-positive bacterial infections in the intensive care unit setting. Crit Care Med 2001;29:N69-74. [PMID: 11345092 DOI: 10.1097/00003246-200104001-00003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
5 Tan TQ. Antibiotic resistant infections due to Streptococcus pneumoniae: impact on therapeutic options and clinical outcome. Curr Opin Infect Dis 2003;16:271-7. [PMID: 12821820 DOI: 10.1097/00001432-200306000-00015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
6 Lacy P, Mcconn Walsh R. The role of antibiotics in the management of acute otitis media in children. Clin Otolaryngol 2002;27:1-3. [DOI: 10.1046/j.0307-7772.2001.00518.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Wiertsema SP, Baynam G, Khoo S, Veenhoven RH, van Heerbeek N, Zhang G, Laing IA, Rijkers GT, Goldblatt J, Sanders EA, Le Souëf PN. Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response. Vaccine 2007;25:306-13. [DOI: 10.1016/j.vaccine.2006.07.024] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
8 Liebowitz LD, Slabbert M, Huisamen A. National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents. J Clin Pathol 2003;56:344-7. [PMID: 12719453 DOI: 10.1136/jcp.56.5.344] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
9 Klugman KP, Feldman C. Streptococcus pneumoniae respiratory tract infections. Curr Opin Infect Dis 2001;14:173-9. [PMID: 11979129 DOI: 10.1097/00001432-200104000-00011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
10 Schoenmakers MCJ, Hament J, Fleer A, Aerts PC, van Dijk H, Kimpen JLL, Wolfs TFW. Risk factors for invasive pneumococcal disease: . Reviews in Medical Microbiology 2002;13:29-36. [DOI: 10.1097/00013542-200201000-00003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Laitinen S, Vaara M, Salo E. Pneumococcal serotype distribution in invasive paediatric disease in Southern Finland before the introduction of vaccine. Scand J Infect Dis. 2010;42:924-930. [PMID: 20735331 DOI: 10.3109/00365548.2010.510532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
12 Wei SC, Norwood J. Diagnosis and management of respiratory tract infections for the primary care physician. Obstet Gynecol Clin North Am 2001;28:283-304. [PMID: 11430177 DOI: 10.1016/s0889-8545(05)70201-1] [Reference Citation Analysis]
13 Bauer T, Ewig S, Marcos MA, Schultze-Werninghaus G, Torres A. Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance? Med Clin North Am 2001;85:1367-79. [PMID: 11680107 DOI: 10.1016/s0025-7125(05)70385-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Poutsiaka DD. Antimicrobial resistance in the chronically critically ill patient. Clin Chest Med 2001;22:87-103, viii. [PMID: 11315461 DOI: 10.1016/s0272-5231(05)70027-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
15 Ramgoolam A, Steele R. Formulations of antibiotics for children in primary care: effects on compliance and efficacy. Paediatr Drugs 2002;4:323-33. [PMID: 11994037 DOI: 10.2165/00128072-200204050-00005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rutala WA, Weber DJ. Registration of disinfectants based on relative microbicidal activity. Infect Control Hosp Epidemiol 2004;25:333-41. [PMID: 15108732 DOI: 10.1086/502401] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
17 Cazzola M, Salzillo A, De Giglio C, Piccolo A, Califano C, Noschese P. Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae. Respiratory Medicine 2005;99:663-9. [DOI: 10.1016/j.rmed.2004.11.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
18 Stenzel M. The HIV-infected patient in the intensive care unit: . Current Opinion in Critical Care 2000;6:330-6. [DOI: 10.1097/00075198-200010000-00005] [Reference Citation Analysis]
19 Ishida T, Maniwa K, Kagioka H, Hirabayashi M, Onaru K, Tomioka H, Hayashi M, Tomii K, Gohma I, Ito Y, Hirai T, Ito I, Mishima M. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adult patients with community-acquired pneumonia in Japan. Respirology 2008;13:240-6. [DOI: 10.1111/j.1440-1843.2007.01214.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
20 Cunha BA. Penicillin resistance in pneumococcal pneumonia: Antibiotics with low resistance potential are effective and pose less risk. Postgraduate Medicine 2015;113:42-54. [DOI: 10.3810/pgm.2003.01.1349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
21 Arguedas A, Soley C, Abdelnour A. Prevenar experience. Vaccine 2011;29:C26-34. [DOI: 10.1016/j.vaccine.2011.06.104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
22 Ledwith M. Pneumococcal conjugate vaccine: . Current Opinion in Pediatrics 2001;13:70-4. [DOI: 10.1097/00008480-200102000-00013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
23 Paradisi J, Corti G, Cinelli R. Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains. Clinical Microbiology and Infection 2001;7:34-42. [DOI: 10.1046/j.1469-0691.2001.00056.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
24 Liu Z, Nachamkin I, Edelstein PH, Lautenbach E, Metlay JP. Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era. Antimicrob Agents Chemother 2012;56:743-50. [PMID: 22123697 DOI: 10.1128/AAC.05122-11] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
25 Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control. 2007;35:S65-164. [PMID: 18068815 DOI: 10.1016/j.ajic.2007.10.007] [Cited by in Crossref: 1340] [Cited by in F6Publishing: 1229] [Article Influence: 95.7] [Reference Citation Analysis]
26 Stahl J, Sage MR. Radiological-pathological correlation: alveolar pattern. Australas Radiol 2001;45:74-97. [PMID: 11259980 DOI: 10.1046/j.1440-1673.2001.00895.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Stratton CW. Antimicrobial resistance in respiratory tract pathogens. Expert Rev Anti Infect Ther 2004;2:641-7. [PMID: 15482226 DOI: 10.1586/14787210.2.4.641] [Reference Citation Analysis]
28 Hoberman A, Paradise JL, Greenberg DP, Wald ER, Kearney DH, Colborn DK. Penicillin Susceptibility of Pneumococcal Isolates Causing Acute Otitis Media in Children: Seasonal Variation. Pediatric Infectious Disease Journal 2005;24:115-20. [DOI: 10.1097/01.inf.0000151092.85759.6d] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
29 Toltzis P, Dul M, O'Riordan MA, Toltzis H, Blumer JL. Impact of amoxicillin on pneumococcal colonization compared with other therapies for acute otitis media. Pediatr Infect Dis J 2005;24:24-8. [PMID: 15665706 DOI: 10.1097/01.inf.0000148880.61449.82] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
30 Cunha BA. COMMUNITY-ACQUIRED PNEUMONIA. Medical Clinics of North America 2001;85:43-77. [DOI: 10.1016/s0025-7125(05)70304-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]